Last Updated on December 31, 2023 by The Health Master
The drug price regulator has fixed the prices of 272 drugs and reviewed the prices of one combination drug during the first six months of the current financial year, besides extending its price control measures on the C-19 related products, according to the Department of Pharmaceuticals (DoP).
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 77 new drugs under the revised Schedule I of the National List of Essential Medicines (NLEM), 2015 during the month of September 2022.
Including these, the cumulative retail price fixation during the six months from April 1, 2022, to September 30, 2022, was for 272 drugs, said the department in a latest monthly review.
During the period, the Authority has also extended the price fixation on liquid medical oxygen (LMO) and oxygen inhalation (medicinal gas) in cylinders, and the ceiling prices fixed on heparin injection at 1000 IU/ml and 5000 IU/ml, till December 31, 2022.
The Authority has also issued 12 preliminary notices to companies based on the monitoring and enforcement activities, and an amount of Rs. 23.85 lakh was recovered towards overcharged amount during the month of September, said the Department.
According to a statement by Bhagwanth Khutba, minister of state for chemicals and fertilizers, in August 2022, NPPA fixed the ceiling prices of 890 scheduled formulations of medicines under NLEM, 2015 till June 30, 2022.
In addition, NPPA has fixed retail prices of 2,023 new drugs under DPCO, 2013 till June. Besides, NPPA has also capped the trade margin of non-scheduled formulations of 42 anti-cancer medicines under the ‘Trade Margin Rationalization’ approach as a pilot for proof of concept, wherein prices of more than 500 brands of medicines were reduced up to 90%, the added.
During the six months, the NPPA has also revised the price of Pune-based Emcure Pharmaceuticals’ HIV drug combination darunavir 800 mg + ritonavir IP 100 mg tablet upwards, following a review order from the DoP.
NPPA has fixed the retail price of darunavir 800 mg + ritonavir IP 100 mg, as Rs. 197.55 per tablet, through a notification on November 8, 2019, while the same combination of Hetero Healthcare Ltd. on November 2, 2018, was fixed at Rs. 212.91 per tablet based on the recommendation of the multidisciplinary committee (MDC) of experts.
The company approached the DoP following this and received a favorable order in June 2021.
The DoP in its order observed that the NPPA could have used the retail price of Rs. 212.91 per tablet for Hetero Healthcare while filing the retail price for Emcure Pharmaceuticals.
After further communications from the DoP and deliberations, the NPPA notified the price of each darunavir ethanolate equivalent to darunavir 800 mg and ritonavir IP 100 mg tablet manufactured by Hetero Labs Ltd and marketed by Emcure Pharmaceuticals, will be Rs. 212.91.
Latest on National Pharmaceutical Pricing Authority (NPPA)
Latest notifications – DPCO / NPPA
Latest Notifications: EC Act (Essential Commodities Act)
FAQs – On DPCO: Drugs (Prices Control) Order, 2013
Govt constitutes 7 member panel to prepare ‘National Drugs Database’
DCGI to SDCs: Accept hard copy of application for registration of Medical Devices
USFDA issues Form 483 with 5 observations to Lupin
IPC introduces draft amendment to microbial contamination in IP 2022
USFDA issues Form 483 with one Observation to Laurus Labs
CDSCO Panel approves Tofacitinib Ointment 2% to Continue Clinical Trial Study
USFDA gives final approval for Paclitaxel injection
This State Pharmacy Council to appoint Pharmacy Inspectors
Medical Stores पर कार्रवाई: नशीली दवाई बेचने पर Licenses cancel, suspend
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
